My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 101

    1.

    Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management.

    Estey EH.

    Am J Hematol. 2012 Jan;87(1):89-99. doi: 10.1002/ajh.22246.

    PMID:
    22180162
    [PubMed - indexed for MEDLINE]

    Related citations

    2.

    Safety and efficacy of total body irradiation, cyclophosphamide, and cytarabine as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.

    Mori T, Aisa Y, Kato J, Yamane A, Nakazato T, Shigematsu N, Okamoto S.

    Am J Hematol. 2012 Apr;87(4):349-53. doi: 10.1002/ajh.23109. Epub 2012 Jan 31.

    PMID:
    22290459
    [PubMed - indexed for MEDLINE]

    Related citations

    3.

    Feasibility of outpatient consolidation chemotherapy in older versus younger patients with acute myeloid leukemia.

    Saini L, Minden MD, Schuh AC, Yee KW, Schimmer AD, Gupta V, Atenafu EG, Murray C, Nixon S, Brandwein JM.

    Am J Hematol. 2012 Mar;87(3):323-6. doi: 10.1002/ajh.22268. Epub 2011 Dec 27.

    PMID:
    22213349
    [PubMed - indexed for MEDLINE]

    Related citations

    4.

    Identification of genomic aberrations associated with disease transformation by means of high-resolution SNP array analysis in patients with myeloproliferative neoplasm.

    Rumi E, Harutyunyan A, Elena C, Pietra D, Klampfl T, Bagienski K, Berg T, Casetti I, Pascutto C, Passamonti F, Kralovics R, Cazzola M.

    Am J Hematol. 2011 Dec;86(12):974-9. doi: 10.1002/ajh.22166. Epub 2011 Sep 22.

    PMID:
    21953568
    [PubMed - indexed for MEDLINE]

    Related citations

    5.

    Utility of 18F-FDG PET/CT in identifying terminal ileal myeloid sarcoma in an asymptomatic patient.

    Lee EY, Leung AY, Anthony MP, Loong F, Khong PL.

    Am J Hematol. 2011 Dec;86(12):1036-7. doi: 10.1002/ajh.22077. Epub 2011 Jul 28. No abstract available.

    PMID:
    21800353
    [PubMed - indexed for MEDLINE]

    Related citations

    6.

    Characteristics of translocation (16;16)(p13;q22) acute myeloid leukemia.

    Eghtedar A, Borthakur G, Ravandi F, Jabbour E, Cortes J, Pierce S, Kantarjian H, Garcia-Manero G.

    Am J Hematol. 2012 Mar;87(3):317-8. doi: 10.1002/ajh.22258. Epub 2012 Jan 7.

    PMID:
    22228403
    [PubMed - indexed for MEDLINE]

    Related citations

    7.

    A basis for updating our approach to resistant acute leukemia.

    Cunningham I.

    Am J Hematol. 2012 Mar;87(3):251-7. doi: 10.1002/ajh.22256. Epub 2012 Jan 28.

    PMID:
    22287495
    [PubMed - indexed for MEDLINE]

    Related citations

    8.

    Treatment of molecular relapse in patients with acute myeloid leukemia using clofarabine monotherapy.

    Racil Z, Toskova M, Dvorakova D, Jeziskova I, Razga F, Buresova L, Timilsina S, Mayer J.

    Am J Hematol. 2011 Oct 12. doi: 10.1002/ajh.22213. [Epub ahead of print] No abstract available.

    PMID:
    22052688
    [PubMed - as supplied by publisher]

    Related citations

    9.

    Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50-70-year old: a phase 1/2 study of the acute leukemia French association.

    Farhat H, Reman O, Raffoux E, Berthon C, Pautas C, Kammoun L, Chantepie S, Gardin C, Rousselot P, Chevret S, Dombret H, Castaigne S.

    Am J Hematol. 2012 Jan;87(1):62-5. doi: 10.1002/ajh.22201. Epub 2011 Nov 10.

    PMID:
    22072535
    [PubMed - indexed for MEDLINE]

    Related citations

    10.

    Salvage therapy with endostatin, low-dose homoharringtonine, and cytarabine in combination with granulocyte-colony stimulating factor for elderly patients with primary refractory acute myeloid leukemia.

    Fang B, Liu Y, Zhou J, Li Y, Song Y.

    Am J Hematol. 2012 Jan;87(1):126-7. doi: 10.1002/ajh.22199. Epub 2011 Nov 10. No abstract available.

    PMID:
    22072502
    [PubMed - indexed for MEDLINE]

    Related citations

    11.

    Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics.

    Ghanem H, Tank N, Tabbara IA.

    Am J Hematol. 2012 Jan;87(1):69-77. doi: 10.1002/ajh.22197. Epub 2011 Nov 10. Review.

    PMID:
    22072438
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    FLAGIDA-lite is an effective regimen for patients between 70 and 80 years with acute myeloid leukemia or refractory anemia with excess blasts-2 and is feasible as outpatient treatment.

    Bermúdez A, Pérez-Vázquez G, Insunza A, Baro J, Colorado M, Conde E, Díez-Gallarreta Z, Gutiérrez ML, López-Duarte M, Olalla I, Sanroma P, Yañez L, Iriondo A, Richard C.

    Am J Hematol. 2012 Jan;87(1):42-4. doi: 10.1002/ajh.22192. Epub 2011 Oct 20.

    PMID:
    22015963
    [PubMed - indexed for MEDLINE]

    Related citations

    13.

    Tailored temozolomide therapy according to MGMT methylation status for elderly patients with acute myeloid leukemia.

    Medeiros BC, Kohrt HE, Gotlib J, Coutre SE, Zhang B, Arber DA, Zehnder JL.

    Am J Hematol. 2012 Jan;87(1):45-50. doi: 10.1002/ajh.22191. Epub 2011 Nov 4.

    PMID:
    22052619
    [PubMed - indexed for MEDLINE]

    Related citations

    14.

    Monosomal karyotype in acute myeloid leukemia predicts adverse treatment outcome and associates with high functional multidrug resistance activity.

    Ahn HK, Jang JH, Kim K, Kim HJ, Kim SH, Jung CW, Kim DH.

    Am J Hematol. 2012 Jan;87(1):37-41. doi: 10.1002/ajh.22193. Epub 2011 Nov 25.

    PMID:
    22120708
    [PubMed - indexed for MEDLINE]

    Related citations

    15.

    Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia.

    Todeschini G, Bonifacio M, Tecchio C, Balter R, Carli G, Stefani PM, Adami F, Zamò A, Tos AP, Marino F, Gherlinzoni F, Marradi P, Semenzato G, Pizzolo G.

    Am J Hematol. 2012 Jan;87(1):22-5. doi: 10.1002/ajh.22189. Epub 2011 Nov 16.

    PMID:
    22086870
    [PubMed - indexed for MEDLINE]

    Related citations

    16.

    Chronic myeloid leukemia 2011: successes, challenges, and strategies--proceedings of the 5th annual BCR-ABL1 positive and BCR-ABL1 negative myeloproliferative neoplasms workshop.

    Mughal TI, Radich JP, Van Etten RA, Quintás-Cardama A, Skorski T, Ravandi F, DeAngelo DJ, Gambacorti-Passerini C, Martinelli G, Tefferi A.

    Am J Hematol. 2011 Sep;86(9):811-9. doi: 10.1002/ajh.22097. No abstract available.

    PMID:
    21850662
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    Clinical and laboratory features of leukemias at the time of diagnosis: an analysis of 1,004 consecutive patients.

    Racil Z, Buresova L, Brejcha M, Prochazkova J, Zounar R, Timilsina S, Razga F, Toskova M, Cetkovsky P, Mayer J.

    Am J Hematol. 2011 Sep;86(9):800-3. doi: 10.1002/ajh.22100. Epub 2011 Aug 2. No abstract available.

    PMID:
    21809370
    [PubMed - indexed for MEDLINE]

    Related citations

    18.

    The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experience.

    Laurenti L, Tarnani M, Nichele I, Ciolli S, Cortelezzi A, Forconi F, Rossi D, Mauro FR, D'Arena G, Del Poeta G, Montanaro M, Morabito F, Musolino C, Callea V, Falchi L, Tedeschi A, Ambrosetti A, Gaidano G, Leone G, Foà R.

    Am J Hematol. 2011 Dec;86(12):1007-12. doi: 10.1002/ajh.22171. Epub 2011 Sep 22.

    PMID:
    21953617
    [PubMed - indexed for MEDLINE]

    Related citations

    19.

    Survival trends among 1,325 patients with chronic lymphocytic leukemia seen over the past 40 years in Israel.

    Shvidel L, Braester A, Bairey O, Rahimi-Levene N, Klepfish A, Herishanu Y, Shtalrid M, Polliack A, Berrebi A; Israeli CLL Study Group.

    Am J Hematol. 2011 Dec;86(12):985-92. doi: 10.1002/ajh.22160. Epub 2011 Sep 14.

    PMID:
    21919037
    [PubMed - indexed for MEDLINE]

    Related citations

    20.

    Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene.

    Elia L, Grammatico S, Paoloni F, Vignetti M, Rago A, Cenfra N, Mecarocci S, Mancini M, Luciani M, Di Raimondo F, Cazzaniga G, Matarazzo M, Moleti ML, Santoro L, Gaidano G, Foà R, Mandelli F, Cimino G.

    Am J Hematol. 2011 Dec;86(12):993-7. doi: 10.1002/ajh.22161. Epub 2011 Sep 22.

    PMID:
    21953510
    [PubMed - indexed for MEDLINE]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk